Edgewise Therapeutics to Present at Upcoming Investor Conferences
09 November 2023 - 12:00AM
Business Wire
Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle
disease biopharmaceutical company, announced today that members of
its senior management team will participate in the following
upcoming investor conferences:
Stifel 2023 Healthcare Conference Presentation:
Wednesday, November 15, 2023, at 10:55 am ET
Piper Sandler 35th Annual Healthcare Conference
Presentation: Wednesday, November 29, 2023, at 8:00 am ET
The presentations will be webcast live; links for the webcasts
can be found on the Edgewise events page and will be accessible for
replay following the presentations. It is recommended that users
connect to the webcasts several minutes prior to the start to
ensure a timely connection.
About Edgewise Therapeutics
Edgewise Therapeutics is a leading muscle disease
biopharmaceutical company developing novel therapeutics for
muscular dystrophies and serious cardiac conditions. The company’s
deep expertise in muscle physiology is driving a new generation of
first-in-class therapeutics. EDG-5506 is an orally administered
skeletal myosin inhibitor in clinical trials in patients with
Becker, Duchenne, and Limb-Girdle muscular dystrophies as well as
McArdle Disease. EDG-7500, currently in a Phase 1 trial, is a novel
cardiac sarcomere modulator for the treatment of HCM and other
disorders of cardiac diastolic dysfunction. The entire team at
Edgewise is dedicated to our mission: changing the lives of
patients and families affected by serious muscle diseases. To learn
more, go to: www.edgewisetx.com or follow us on LinkedIn, X
(formerly Twitter), Facebook, Instagram and Threads.
This press release contains hyperlinks to information that is
not deemed to be incorporated by reference into this press
release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231108004645/en/
Investors & Media Michael Carruthers Chief Financial
Officer ir@edgewisetx.com
Edgewise Therapeutics (NASDAQ:EWTX)
Historical Stock Chart
From Apr 2024 to May 2024
Edgewise Therapeutics (NASDAQ:EWTX)
Historical Stock Chart
From May 2023 to May 2024